Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) News
Market Cap: $12.07B
Avg Volume: 775.96K
Industry: Regulated Water
Sector: Utilities
52W Range: $13.1-18.36
Website: Companhia de Saneamento Básico do Estado de São Paulo - SABESP
Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF)
This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and microvillus inclusion disease (MVID) in the US, EU, and/or Middle East/North Africa regions Availability of first IIT proof-of-concept results potentially in H1 2025 Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both SBS-IF and MVID SAN FRANCISCO, CA / ACCESS Newswire / February 19, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family companies Napo Pharmaceuticals ("Napo") and Napo Therapeutics today announced that the clinical protocol for Napo's Phase 2 study to evaluate the efficacy of crofelemer, Jaguar's novel plant-based anti-secretory prescription drug, for the indication of SBS-IF in adults has received regulatory clearance from health authorities in Italy and Germany, where the trial will be conducted. The study initiated yesterday, February 18, 2025.
accessnewswire.com
Read More
Recent Price Trend in Sabesp (SBS) is Your Friend, Here's Why
Sabesp (SBS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
zacks.com
Read More
Sabesp (SBS) is a Top-Ranked Momentum Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com
Read More
Are Utilities Stocks Lagging Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) This Year?
Here is how Sabesp (SBS) and Telecom Italia (TIIAY) have performed compared to their sector so far this year.
zacks.com
Read More
Is Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.com
Read More
U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health's Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) Begins
The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and/or microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder, in the US, EU, and/or Middle East/North Africa (MENA) regions; availability of IIT proof-of-concept results potentially in Q2 2025 Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both SBS-IF and MVID SAN FRANCISCO, CA / ACCESSWIRE / December 6, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that an independent IIT in the U.S. to evaluate the efficacy and safety of crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the rare disease indication of short bowel syndrome with intestinal failure (SBS-IF) in adults has begun. An overview of the study can be viewed on the ClinicalTrials.gov website.
accesswire.com
Read More
Sabesp Q3: Good Result, But Macro Scenario Continues To Leave Me Skeptical
Recommend holding Sabesp shares post-3Q24 results due to good trends, but valuation lacks safety margin amid Brazilian economic instability. Net revenues rose 9.6% y/y to $987 million, driven by tariff adjustments and privatization impacts on corporate accounting. Operating costs fell 3.1% y/y, with a strong EBITDA margin of 59.9%, and net income increased 43.7% y/y to $201 million.
seekingalpha.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2024 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ET Company Participants Luiz Tiberio - IR Superintendent Carlos Piani - CEO Daniel Szlak - Financial Director, Investor Relations Conference Call Participants Luiz Tiberio Good morning, everyone. My name is Luiz Roberto Tiberio.
seekingalpha.com
Read More
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting and Postgraduate Course from subgroup analyses of the primary endpoint of the pivotal Phase III clinical trial, STARS, evaluating the treatment effect of apraglutide by baseline demographics and disease-specific characteristics in adults with short bowel syndrome with intestinal failure.
businesswire.com
Read More
4 Stocks to Buy From the Promising Water Supply Industry
Water utilities, AWK, SBS, AWR and SJW, are likely to benefit from stable demand for water and wastewater services. Capital-intensive utilities are set to gain from interest rate cuts.
zacks.com
Read More
Sabesp (SBS) Is a Great Choice for 'Trend' Investors, Here's Why
Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
zacks.com
Read More
Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that the country of Jordan's Industrial Property Protection Directorate has issued a new patent to Jaguar family company Napo Pharmaceuticals (Napo) for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very pleased that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
accesswire.com
Read More
Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer Napo has approximately 230 patents issued and pending Jaguar is supporting independent investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare congenital diarrheal disorder (CDD), in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2024 and throughout 2025 SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Hong Kong's Intellectual Property Department has issued a new patent to Jaguar family company Napo Pharmaceuticals for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of chloride-ion transport such as crofelemer, Jaguar's novel plant-based prescription drug. "We are very happy that this patent has been issued and believe that it further enhances our intellectual property protection for crofelemer for our core rare disease target indication of SBS," said Lisa Conte, Jaguar's founder, president, and CEO.
accesswire.com
Read More
Here's Why Momentum in Sabesp (SBS) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
zacks.com
Read More
Here's Why Sabesp (SBS) is Poised for a Turnaround After Losing -11.66% in 4 Weeks
Sabesp (SBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
zacks.com
Read More
SBS or GWRS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks presents investors with the better value opportunity right now?
zacks.com
Read More
Should Value Investors Buy Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.com
Read More
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present late-breaking data during the 2024 Digestive Disease Week® (DDW) meeting from its pivotal Phase III clinical trial, STARS, which evaluated the efficacy and safety of once-weekly subcutaneous apraglutide in adult patients with short bowel syndrome with intestinal failure (SBS-IF). These findings build on the positive topline data that Ironwood previously announced in February 202.
businesswire.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2024 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q1 2024 Earnings Conference Call May 10, 2024 10:00 AM ET Company Participants Luiz Roberto Tiberio - IR Superintendent André Salcedo - CEO Catia Pereira - CFO and IR Officer Conference Call Participants Luiz Roberto Tiberio Hello. Good morning, everyone, and welcome to our earnings call for Q1 2024.
seekingalpha.com
Read More
What Makes Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) a Good Fit for 'Trend Investing'
If you are looking for stocks that are well positioned to maintain their recent uptrend, Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
zacks.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript
seekingalpha.com
Read More
SBS vs. GWRS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Utility - Water Supply sector have probably already heard of Sabesp (SBS) and Global Water Resources, Inc. (GWRS). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
Read More
Here's Why 'Trend' Investors Would Love Betting on Sabesp (SBS)
Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
zacks.com
Read More
Sabesp: Privatization Just Around The Corner, Q3 Results Still Provide Room For Upside
Privatization of Brazilian water management company Sabesp is progressing, with a likely completion by the first half of 2024. The regulatory terms of the privatization will determine the company's long-term efficiency and potential for growth. The optimistic scenario envisions efficiency gains and a potential EV/RAB increase to 1.5x, suggesting a substantial upside.
seekingalpha.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2023 Earnings Conference Call November 10, 2023 9:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of IR Andre Salcedo - CEO Catia Pereira - CFO and IRO Conference Call Participants Luiz Roberto Tiberio Good morning, everyone. Welcome to the Earnings Conference Call for SABESP for the Third Quarter.
seekingalpha.com
Read More
Sabesp: Privatization Gains Momentum, Stock Is A Buy (Rating Upgrade)
Sabesp's significant steps toward privatization, including the approval of privatization guidelines and a follow-on model, have boosted confidence in the company's prospects. In Q2, Sabesp reported robust financial results, with recurring EBITDA increasing significantly year-over-year. Sabesp's current valuation, with the potential for reduced cost of capital and improved long-term operating performance as a private sector company, suggests significant upside potential.
seekingalpha.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q2 2023 Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q2 2023 Earnings Conference Call August 11, 2023 10:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of Investor Relations Andre Salcedo - Chief Executive Officer Catia Pereira - Chief Financial Officer and Investor Relations Officer Luiz Roberto Tiberio Good morning. Welcome to the SABESP Second Quarter Earnings Release Call.
seekingalpha.com
Read More
Sabesp Stock: Evaluating Privatization's Impact, Neutral Stance
The potential privatization of the Brazilian water and waste management company, Sabesp, has impacted its shares, presenting an opportunity to enhance the company's efficiency. Sabesp's recent earnings results were satisfactory, showcasing a 17% year-over-year increase in net operating revenues despite recent volatility and a drop in net income, albeit with minor setbacks. While the company currently trades at an undervalued price, I adopt a cautious approach due to the risks associated with the changes of "Basic Sanitation Legal Framework" in Brazil.
seekingalpha.com
Read More
Survey & Ballot Systems Launches Text Message Invites for Increased Voter Engagement
SBS launches verified text message invites to help member organizations increase voter participation within director elections, bylaw votes, mergers and contract ratification votes. EDEN PRAIRIE, Minn., March 16, 2023 /PRNewswire-PRWeb/ — Survey & Ballot Systems (SBS), a leading provider of online voting and governance software solutions, is excited to announce the launch of its newest […]...
headlinesoftoday.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2022 - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP. (NYSE:SBS ) Q3 2022 Earnings Conference Call November 17, 2022 9:00 AM ET Company Participants Luiz Tiberio - Resource Funding and IRO Officer Benedito Braga - Chief Executive Officer of SABESP Osvaldo Garcia - Chief Financial Officer and Investor Relations Officer Marcelo Miyagui - Superintendent for Accounting Conference Call Participants Carolina Carneiro - Credit Suisse Henrique Peretti - JPMorgan Operator Good morning, everyone.
seekingalpha.com
Read More
Brazil Election Sends EWZ, SBS, VALE, PBR Stocks Soaring Today
Today's broad-based rally has provided a key lift for many top stocks in investors' portfolios. That said, among the biggest gainers today is an intriguing group of stocks.
investorplace.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP's (SBS) CEO Benedito Braga on Q4 2021 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP's (SBS) CEO Benedito Braga on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
Read More
3 High Return Non-Cyclical Stocks
Investors may want to consider the following non-cyclical stocks, as their earnings yields (as calculated via Joel Greenblatt (Trades, Portfolio)'s method) are outperforming the 20-year high-quality market corporate bond spot rate of 3.07% as of the writing of this article.
gurufocus.com
Read More
4 Stocks Shining as Bargains
If you are screening the market for bargain opportunities among U.S.-listed equities, then you may want to consider the following stocks, since they meet the criteria listed below:
gurufocus.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) CEO Benedito Braga on Q3 2021 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) CEO Benedito Braga on Q3 2021 Results - Earnings Call Transcript
seekingalpha.com
Read More
Facebook wraps up deals with Australia media firms, TV broadcaster SBS not included
Facebook Inc has told Australian publishers it has stopped negotiating licencing deals, an email to the industry seen by Reuters showed, a move which came just six months after the passing of a law designed to make tech giants pay for news content.
reuters.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) CEO Benedito Braga on Q2 2021 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) CEO Benedito Braga on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com
Read More
Sabesp Announces 2Q21 Results
SÃO PAULO, Aug. 12, 2021 /PRNewswire/ -- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (B3: SBSP3; NYSE: SBS), one of the largest water and sewage services providers in the world based on the number of customers, announces today its second quarter of 2021 results. The Company recorded a net income of R$ 773.1 million in 2Q21, compared to R$ 378.2 million in 2Q20.
prnewswire.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP's (SBS) Management on Q1 2021 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP's (SBS) Management on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2020 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2020 Results - Earnings Call Transcript
seekingalpha.com
Read More
TPG Group Holdings (SBS) Advisors, Inc. Buys C3..
Fort Worth, TX, based Investment company TPG Group Holdings (SBS) Advisors, Inc. (Current Portfolio) buys C3.ai Inc, McAfee Corp, Vaxcyte Inc, Eros STX Global Corp, Thomson Reuters Corp, sells Uber Technologies Inc, Interactive Brokers Group Inc, Accel Entertainment Inc, Ross Stores Inc, Playa Hotels & Resorts NV during the 3-months ended 2020Q4, according to the most recent filings of the investment company, TPG Group Holdings (SBS) Advisors, Inc.. As of 2020Q4, TPG Group Holdings (SBS) Advisors, Inc. owns 39 stocks with a total value of $9 billion.
gurufocus.com
Read More
10 Cheap Stocks Under $10 That Don't Deserve Your Time or Money
There are plenty of cheap stocks out there, but don't confuse inexpensive for undervalued; these 10 stocks under $10 should be avoided. The post 10 Cheap Stocks Under $10 That Don't Deserve Your Time or Money appeared first on InvestorPlace.
investorplace.com
Read More
3 Stock Picks With a Low Shiller Price-Earnings Ratio
Choosing stocks with compelling Shiller price-earnings ratios increases the likelihood of identifying value opportunities, in my opinion. Thus, investors may want to have a look at the following stocks, as their Shiller price-earnings ratios are standing below the S&P 500 Index's historical average of 16.80 as of Friday, March 12.
gurufocus.com
Read More
The Best Water Stocks of 2020 -- Are Any Buys for 2021?
Here's how the 10 largest dividend-paying water utility stocks stack up.
fool.com
Read More
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2020 Results - Earnings Call Transcript
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q3 2020 Results - Earnings Call Transcript
seekingalpha.com
Read More